Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025189 · ClinicalTrials.gov registry record · NA
The Effect of Grape Consumption on Increasing the Good Bacteria in the Human Intestine
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05025189 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants.
The verdict
NCT05025189, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot study will assess the ability of daily consumption of one dose (2 servings) of freeze-dried whole table grape powder, made from conventionally grown grapes to alter the composition of the bacteria that live in the intestines in healthy subjects. The grape powder contains 46g of individually quick frozen (IQF) grapes, which is equivalent to 252g fresh fruit. 20 subjects will will consume the beige diet for 4 weeks followed by one dose (two servings) of standardized Freeze-Dried Whole Table Grape Powder (46g) daily for 4 weeks. The primary objective of this pilot study is to determine changes in the gut microbiome. Stool samples will be collected at 4 and 8 weeks for bacterial DNA to determine changes in the bacteria that live in the intestines. You will be asked to avoid foods rich in polyphenols including dark chocolate and cocoa products, dried herbs, berries, coffee, tea, flaxseeds, nuts (chestnut, hazelnut), olive and artichoke for the duration of the study.
Interventions
- OTHER Table Grape Powder
- OTHER Beige Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025189
The ClinicalTrials.gov registry entry for NCT05025189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Table Grape Powder is the first listed.
NCT05025189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05025189 about?
NCT05025189 is a clinical study titled "The Effect of Grape Consumption on Increasing the Good Bacteria in the Human Intestine". This pilot study will assess the ability of daily consumption of one dose (2 servings) of freeze-dried whole table grape powder, made from conventionally grown grapes to alter the composition of the bacteria that live in the intestines in healthy subjects. The grape powder contains 46g of individual...
What is the current status of trial NCT05025189?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-10-05. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT05025189?
The interventions under investigation include: Table Grape Powder (OTHER), Beige Diet (OTHER).
Who is sponsoring clinical trial NCT05025189?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.